CMS believes the proposed rebate reduction policies balance providing appropriate financial relief for manufacturers in certain circumstances, including when there is a severe supply disruption resulting from exogenous circumstances outside of a manufacturer's control, while not incentivizing manufacturers to delay taking appropriate steps to resolve a drug shortage or severe supply chain disruption to avoid an obligation to pay rebates
Optimal Care for Kidney Health
BECKER: And if we do look at states where this has happened, even countries where this has happened, I wonder, Alan Blum, what do we know, what does the research tell us about menthol bans in Massachusetts and California and it's a little bit different when you've got a state that maybe is a 20 minute, 10 minute drive away, where menthol is accessible, but just once you cross that border, it isn't
The unit size of these kits was also unclear, which made price comparisons with the submitted invoices difficult